Journal ArticleDOI
Global Cancer Incidence and Mortality Rates and Trends—An Update
Reads0
Chats0
TLDR
Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates.Abstract:
There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for 2003-2007. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs.read more
Citations
More filters
Journal ArticleDOI
Healthy lifestyle and breast cancer risk: A case-control study in Morocco.
Mohamed Khalis,Mohamed Khalis,Veronique Chajes,Aurelie Moskal,Carine Biessy,Inge Huybrechts,Sabina Rinaldi,Laure Dossus,Hafida Charaka,Nawfel Mellas,Chakib Nejjari,Joan M. Dorn,Amr S. Soliman,Isabelle Romieu,Karima El Rhazi,Barbara Charbotel +15 more
TL;DR: Findings suggest that BC prevention policies should include strategies for engaging Moroccan women in healthy lifestyles, and high HLI scores were associated with decreased risk of BC in Moroccan women.
Journal ArticleDOI
Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis.
TL;DR: A significant association of omentin level with greater risk of colorectal, pancreas, and breast cancers especially in overweight/obese subjects is indicated in this comprehensive meta-analysis of observational studies.
Journal ArticleDOI
MicroRNA-31 triggers G2/M cell cycle arrest, enhances the chemosensitivity and inhibits migration and invasion of human gastric cancer cells by downregulating the expression of zeste homolog 2 (ZH2).
Ke-Kang Sun,Xiao-Jun Shen,Dong Yang,Ming-qiang Gan,Gang Liu,Yi-fan Zhang,Peng Hua,Hao-dong Wang,Xiaoyang Wu +8 more
TL;DR: It is concluded that miR-31 acts as a tumor suppressor and may prove essential in the treatment of GC.
Journal ArticleDOI
Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy.
Liujiang Song,Xiaojun Tao,Li Lin,Chao Chen,Hui Yao,Guangchun He,Guangyang Zou,Zhong Cao,Shichao Yan,Lu Lu,Huimei Yi,Di Wu,Siyuan Tan,Wanxin Ouyang,Zhifei Dai,Xiyun Deng +15 more
TL;DR: This is the first demonstration of nanohybrids for efficient inhibition of CSCs derived from TNBC, offering a new option for the TNBC treatment and being more effective than free LV in inhibiting the growth of breast cancer xenografts and the stemness properties in vivo.
Journal ArticleDOI
Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation
Michio Iwata,Lisa Hirose,Hiroshi Kohara,Hiroshi Kohara,Jiyuan Liao,Jiyuan Liao,Ryusuke Sawada,Sayaka Akiyoshi,Kenzaburo Tani,Kenzaburo Tani,Yoshihiro Yamanishi,Yoshihiro Yamanishi +11 more
TL;DR: This work analyzes chemically induced gene expression data of 1112 drugs on 66 human cell lines and searches for drugs that inactivate pathways involved in the growth of cancer cells (cell cycle) and activate pathways that contribute to the death of cancer Cells.
References
More filters
Journal ArticleDOI
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
Journal ArticleDOI
The global health burden of infection-associated cancers in the year 2002.
TL;DR: The fraction of the different types of cancer, and of all cancers worldwide and in different regions, has been estimated using several methods; primarily by reviewing the evidence for the strength of the association (relative risk) and the prevalence of infection in different world areas.
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]
J Ferlay,I Soerjomataram,M Ervik,R Dikshit,S Eser,Colin Mathers,M Rebelo,D.M. Parkin,David Forman,Freddie Bray,S Elser,M Ervick,Donald Maxwell Parkin +12 more
Journal ArticleDOI
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
TL;DR: The authors update the incidence trends through 1994 and further consider the trends by age group.